Liquidia Corp. (LQDA)
32.59
-0.09
(-0.28%)
USD |
NASDAQ |
Dec 11, 16:00
32.60
+0.01
(+0.03%)
After-Hours: 20:00
Liquidia Cash from Investing (Quarterly): -0.911M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| United Therapeutics Corp. | 140.90M |
| Bruker Corp. | -23.80M |
| Integer Holdings Corp. | -20.27M |
| Armata Pharmaceuticals, Inc. | -0.242M |
| AIM ImmunoTech, Inc. | 0.296M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.77M |
| Cash from Financing (Quarterly) | -5.245M |
| Free Cash Flow | -104.33M |
| Free Cash Flow Per Share (Quarterly) | -0.1237 |
| Free Cash Flow to Equity (Quarterly) | -53.62M |
| Free Cash Flow to Firm (Quarterly) | -3.736M |
| Free Cash Flow Yield | -3.75% |